Nanodiamonds activate blood platelets and induce thromboembolism.

AIM Nanodiamonds (NDs) have been evaluated for a wide range of biomedical applications. Thus, thorough investigation of the biocompatibility of NDs has become a research priority. Platelets are highly sensitive and are one of the most abundant cell types found in blood. They have a central role in hemostasis and arterial thrombosis. In this study, we aim to investigate the direct and acute effects of carboxylated NDs on platelet function. METHODS In this study, pro-coagulant parameters such as platelet aggregability, intracellular Ca(2+) flux, mitochondrial transmembrane potential (ΔΨm), generation of reactive oxygen species, surface exposure of phosphatidylserine, electron microscopy, cell viability assay and in vivo thromboembolism were analyzed in great detail. RESULTS Carboxylated NDs evoked significant activation of human platelets. When administered intravenously in mice, NDs were found to induce widespread pulmonary thromboembolism, indicating the remarkable thrombogenic potential of this nanomaterial. CONCLUSION Our findings raise concerns regarding the putative biomedical applications of NDs pertaining to diagnostics and therapeutics, and their toxicity and prothrombotic properties should be critically evaluated.

[1]  G. Salido,et al.  Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets , 2007, Journal of thrombosis and haemostasis : JTH.

[2]  Saber M Hussain,et al.  Are diamond nanoparticles cytotoxic? , 2007, The journal of physical chemistry. B.

[3]  Jacqueline A. Johnson,et al.  Interpretation of the Raman spectra of ultrananocrystalline diamond , 2005 .

[4]  C. Libert,et al.  Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo , 2009, The Journal of experimental medicine.

[5]  Huan-Cheng Chang,et al.  Adsorption and immobilization of cytochrome c on nanodiamonds. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[6]  Lloyd M. Smith,et al.  DNA-modified nanocrystalline diamond thin-films as stable, biologically active substrates , 2002, Nature materials.

[7]  Xueyuan Chen,et al.  Energy levels, fluorescence lifetime and Judd–Ofelt parameters of Eu3+ in Gd2O3 nanocrystals , 2007 .

[8]  James G. White, Gines Escolar EDTA-induced changes in platelet structure and function: adhesion and spreading , 2000, Platelets.

[9]  A. Goga,et al.  Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment , 2011, Science Translational Medicine.

[10]  Yang Xu,et al.  Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. , 2010, ACS nano.

[11]  W. D. de Heer,et al.  Carbon Nanotubes--the Route Toward Applications , 2002, Science.

[12]  M. Gelderman,et al.  Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. , 2009, Nano letters.

[13]  Kuang-Kai Liu,et al.  Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. , 2009, Biomaterials.

[14]  A. Pandey,et al.  Toxicity of graphene in normal human lung cells (BEAS-2B). , 2011, Journal of biomedical nanotechnology.

[15]  John J. Schlager,et al.  Differential biocompatibility of carbon nanotubes and nanodiamonds , 2007 .

[16]  Amit Jain,et al.  Carbon nanotubes and their toxicity , 2007 .

[17]  W. Bergmeier,et al.  Novel molecules in calcium signaling in platelets , 2009, Journal of thrombosis and haemostasis : JTH.

[18]  A. Buczyński,et al.  Generation of reactive oxygen species in blood platelets , 2002, Platelets.

[19]  H. Dai,et al.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Yanli Chang,et al.  In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.

[21]  V. Bondar,et al.  [Destruction of human blood cells upon interaction with detonation nanodiamonds in experiments in vitro]. , 2004, Biofizika.

[22]  Wei Huang,et al.  Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.

[23]  Yuanwei Chen,et al.  Biodistribution and fate of nanodiamonds in vivo , 2009 .

[24]  J. Robertson,et al.  Interpretation of Raman spectra of disordered and amorphous carbon , 2000 .

[25]  Alexey P. Puzyr,et al.  Nanodiamonds with novel properties : A biological study , 2007 .

[26]  Tanmay Bera,et al.  Characterization of antiplatelet properties of silver nanoparticles. , 2009, ACS nano.

[27]  H. Gómez,et al.  GOX-functionalized nanodiamond films for electrochemical biosensor , 2011 .

[28]  A. Dvorak Procedural guide to specimen handling for the ultrastructural pathology service laboratory , 1987 .

[29]  Chen Jiang,et al.  Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. , 2009, Biomaterials.

[30]  Dean Ho,et al.  Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy , 2011, Advanced materials.

[31]  D. Dash,et al.  Characterization of the effects of propranolol on the physical state of platelet membrane. , 1990, Archives of biochemistry and biophysics.

[32]  Debabrata Dash,et al.  Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. , 2012, ACS nano.

[33]  Electron field emission from patterned nanocrystalline diamond coated a-SiO2 micrometer-tip arrays , 2008 .

[34]  Chia-Liang Cheng,et al.  Biocompatible and detectable carboxylated nanodiamond on human cell , 2007 .

[35]  Xue-Qing Zhang,et al.  Triggered release of therapeutic antibodies from nanodiamond complexes. , 2011, Nanoscale.

[36]  Jui‐I Chao,et al.  Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy , 2010, Nanotechnology.

[37]  Fwu-Shan Sheu,et al.  Biosensing properties of diamond and carbon nanotubes. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[38]  K. R. Atkinson,et al.  Strong, Transparent, Multifunctional, Carbon Nanotube Sheets , 2005, Science.

[39]  H. Daniel,et al.  Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. , 2008, Journal of agricultural and food chemistry.

[40]  A. Mathur,et al.  Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. , 2000, Cardiovascular research.

[41]  L. Forró,et al.  Cellular toxicity of carbon-based nanomaterials. , 2006, Nano letters.

[42]  S. Shrivastava,et al.  Thrombus inducing property of atomically thin graphene oxide sheets. , 2011, ACS nano.

[43]  V. Bondar,et al.  Design of a luminescent biochip with nanodiamonds and bacterial luciferase , 2004 .

[44]  J. Rosado Acidic Ca(2+) stores in platelets. , 2011, Cell calcium.

[45]  V. Bondar,et al.  Applications of nanodiamonds for separation and purification of proteins , 2004 .

[46]  Houjin Huang,et al.  Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles. , 2009, Biomaterials.

[47]  P. Balaram,et al.  Fluorescent probe studies of mixed micelles of phospholipids and bile salts. Effect of cholesterol incorporation. , 1980, Biochimica et biophysica acta.

[48]  R. Garrell,et al.  Surface-modified diamond nanoparticles as antigen delivery vehicles. , 1995, Bioconjugate chemistry.

[49]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[50]  M. Misra,et al.  Bifacial dye-sensitized solar cells based on vertically oriented TiO2 nanotube arrays , 2010, Nanotechnology.

[51]  Huan-Cheng Chang,et al.  Bright fluorescent nanodiamonds: no photobleaching and low cytotoxicity. , 2005, Journal of the American Chemical Society.